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controlled prevention methods, and reproductive health.
These findings must then be translated into ethical policy
and practice. 
HIV among Young Women in 
Developing Countries
Youths (persons 15–24 years of age) are a major part of
the HIV epidemic around the world, making up an estimat-
ed half of new HIV infections, and young women are typ-
ically infected earlier than are men. Young women have
both biological and social vulnerabilities. They can be sus-
ceptible to “sugar daddy” relationships, they are vulnera-
ble to sex trafficking or coercion, and they have less
education, including HIV prevention education, than their
male counterparts. Some countries have had success in
reducing HIV among young women; however, many pro-
gram challenges remain: lack of evaluation, limited
resources, the unique vulnerabilities of youth ignored, and
the lack of influence by young persons. 
Fifteen million children 15 years of age and younger
have lost one or both parents to AIDS, and this situation
also presents challenges, including increased risk of sexu-
al exploitation, the loss of educational opportunities as
young people are forced to leave school because they lack
school funds or must work to support remaining family
members, and the need for HIV prevention education that
addresses orphans' special needs.
Some promising youth programs have been initiated,
among them curriculum-based programs, peer education,
and voluntary counseling and testing; however, more
resources and evaluation must be devoted to youth pro-
grams, and these programs should view youth as assets,
not as problems. 
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Hepatitis B in Women:
Domestically and
Internationally
Globally, hepatitis B virus (HBV) infection is a major
cause of infectious disease-related death, causing approxi-
mately 620,000 deaths annually. Without hepatitis B vac-
cination, an estimated 1.4 million HBV-related deaths
would occur in the 2000 birth cohort over the lifetime of
the cohort. HBV infections acquired in the perinatal and
early childhood periods account for 21% and 48%, respec-
tively, of HBV-related deaths worldwide. Thus, routine
vaccination of infants and children serves as the basis for a
global hepatitis B prevention program. 
In 1992, the World Health Organization recommended
that hepatitis B vaccine be included in childhood immu-
nization programs in all countries, but because of financial
constraints, many countries were unable to initially imple-
ment this recommendation. In 1999, a global initiative
began to make hepatitis B vaccine available to children liv-
ing in 69 of the world's poorest countries, and by the end
of 2003, routine childhood hepatitis B vaccination was
included in national immunization programs in  >151
countries. However, many countries, mainly in sub-
Saharan Africa, have not yet introduced the vaccine, and
coverage with the three-dose vaccination series remains
low in many countries that have introduced the vaccine.
When all countries have introduced the vaccine and cover-
age with the three-dose vaccination series reaches 90%, up
to 84% of global HBV-related deaths will be prevented.
Hepatitis B in the United States
In the United States, an estimated 5% of the civilian,
noninstitutionalized population has serologic evidence of
past or present HBV infection, and 0.4%-0.5% have chron-
ic infection and are the primary source of infection for oth-
ers. From 1990 through 2002, the incidence of reported
acute hepatitis B declined 67%. The incidence of acute
hepatitis B among men has been consistently higher than
among women. In 1990, the incidence among men and
women was 9.8 and 6.3 per 100,000, respectively; in 2002,
the incidence was 3.7 and 2.2 per 100,000, respectively.
Overall, incidence among women has declined more than
among men. Trends in acute hepatitis B reflect poor vacci-
nation coverage among persons who engage in high-risk
behavior.
Persons at high risk for HBVinfection often seek health
care in settings in which vaccination services could be pro-
vided. During 1996–1998, approximately half of persons
with reported acute hepatitis B previously had been treat-
ed for a sexually transmitted disease (STD) or incarcerat-
ed: 89% of injection drug users, 35% of men who have sex
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with reported acute hepatitis B had been previously incar-
cerated or treated for an STD. Both STD clinics and cor-
rectional facilities are settings in which hepatitis B
vaccination services are recommended. 
Programmatic Success in High Risk Settings
In August 1999, Denver Public Health (DPH) began
offering hepatitis B vaccine to adults at high risk in the
public STD clinic. Initial funding for the vaccine was first
allocated by the Denver City Council. Patients were asked
if they had a history of hepatitis B vaccination or disease
and questioned about risk behavior; no serologic screening
was done. The selective vaccination process was cumber-
some, and clinicians required frequent reminders to imple-
ment it. Of clients seen in the STD clinic, 58% accepted
the vaccine and were directed to receive it in the immu-
nization clinic in the same building. Of clients who agreed
to the free vaccine, 29% left before receiving it.
Procedures changed when additional funding was secured
in January 2002. Client selection was discontinued, and all
clients of the STD and HIV Counseling and Testing clinics
were offered vaccine, which increased its initial accept-
ance to 77%. Vaccination rates were further improved by
having personnel available to vaccinate clients on site,
before they left the clinic. 
DPH used a vaccine registry, adapted from one imple-
mented to track pediatric vaccinations, to assess clients'
vaccination status before doses were given. The results
indicated that clients were not differentiating between vac-
cinations and various other tests or medications in self-
reporting of immunization status. Use of the vaccine
registry was crucial for evaluating completion rates and
eliminating revaccination of persons already immunized. 
A highly successful hepatitis B vaccination program
can be established within another public health infrastruc-
ture. The process requires commitment from all involved
programs because changes in service delivery are needed
to accommodate vaccination. The largest issue confronting
programs is continued funding for vaccine. 
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Refugees, Forced
Displacement, and War
Women make up high proportions of refugee and inter-
nally displaced populations, and they suffer unique conse-
quences of war and conflict because of gender-based
violence, discrimination, and caretaking roles. Refugee
women are especially vulnerable to infectious disease, as
well as threats to their mental health and physical safety. 
Infectious Causes of Maternal Death 
in Refugee Populations in Afghanistan
The Reproductive Age Mortality Survey (RAMOS) in
Afghanistan consisted of death identification followed by
death investigation. The study identified 357 deaths of
women of reproductive age (15–49 years) among residents
of  16,000 Afghani households and investigated 80% of
these deaths through the verbal autopsy method. The
maternal death rate is extremely high (1,600–2,200 deaths
per 100,000 live births) in Afghanistan as a whole, and the
estimate in one study site was the highest ever recorded
(6,500/100,000 live births in Ragh, Badakshan). The vast
majority of maternal deaths were attributed to direct
obstetric causes. Infectious causes, primarily tuberculosis,
malaria, and postpartum sepsis, accounted for 12% of
deaths. Tetanus, tuberculosis, and malaria often claimed
women’s lives while they were pregnant.
Women faced substantial barriers to care, and very few
accessed preventive or curative services. In a country of
very low resources and conflict such as Afghanistan, policy
development and program implementation to reduce mater-
nal deaths are challenging. Causes of maternal death are
multifactorial and cannot be resolved simply by increasing
the percentage of deliveries by skilled birth attendants.
Infectious causes of death identified in this study illustrate
the need for comprehensive maternity care, including pre-
conceptional, prenatal, and postnatal care, integrated with
other reproductive health and primary care services. 
Impact of War on Women’s Health: Refugees
from Liberia and Sierra Leone in Nigeria
A study carried out between January and March 2004
with Liberian refugee women residing in the United
Nations refugee camp at Oru village in Ogun State,
Nigeria, shows how forced migration contributes to
increased incidence of both communicable and noncom-
municable diseases in women. Liberia’s civil war resulted
in approximately 215,000 refugees at the end of 2001;
50% to 80% of these refugees were women. During the
civil war, an estimated 40% of all Liberian women were
raped. Loss of family forces women to depend on men and
may lead to rape, forced marriage, prostitution, domestic
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